Cargando…
Tigecycline-associated hypofibrinogenemia: A case report and review of the literature
Tigecycline, a glycylcycline-derived antibacterial that has been approved for the treatment of various infections, is widely used for multi-drug resistant bacteria. Coagulopathy is an uncommon side effect during tigecycline treatment and is easily overlooked when it occurs. We reported the effect of...
Autores principales: | Wu, Pei-Chun, Wu, Chien-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857890/ https://www.ncbi.nlm.nih.gov/pubmed/29560313 http://dx.doi.org/10.1016/j.idcr.2018.01.003 |
Ejemplares similares
-
Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature
por: Fan, Qiaomei, et al.
Publicado: (2020) -
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021) -
A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia
por: Yılmaz Duran, Fulya, et al.
Publicado: (2018) -
A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia
por: Wu, Xiaoqin, et al.
Publicado: (2017) -
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)